Asthma is the inflammation of the airways when exposed to environmental triggers or stress. It is often confusing, whilst suffering from mind clouding symptoms such as shortness of breath and panic, to know which medication to use and when to take it. An estimated 300 million people worldwide and rising suffer from asthma. Approximately 250,000 people die prematurely each year from asthma and almost all of these deaths are avoidable. Asthma is a silent disease and a silent pandemic. Respia empowers the user to take control and creates behavioural change in the long term management of asthma. It is the complete redesign of existing aerosol inhalers coupled with a world first wearable patch that tracks respiratory health. Respia encourages the user to respond to the early signs of lung inflammation and improves quality of life.